Hercules Capital Provides $185M Growth Facility to NorthStar Medical
HTGC sits 23% above its 52-week low of $13.7.
Summary
Hercules Capital has provided a multi-year growth capital facility of up to $185 million to NorthStar Medical Technologies, with $100 million available upfront. The financing will fund expansion of Ac-225 isotope production and radiopharmaceutical manufacturing, addressing a supply bottleneck in the radiopharma space. NorthStar's FDA-accepted Ac-225 DMF and plans for a high-capacity line shift add regulatory and operational momentum. For Hercules, this represents a significant new commitment in a high-growth niche, adding to its record Q2 originations of $0.9 billion. The deal's size relative to Hercules' $3.16 billion market cap is modest but strategically notable.
At the time of this announcement, HTGC was trading at $16.90 on NYSE in the Finance sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $13.70 to $19.25. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.